Kawai V K, Levinson R T, Adefurin A, Kurnik D, Collier S P, Conway D, Stein C M
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN, USA.
Clin Endocrinol (Oxf). 2017 Aug;87(2):149-155. doi: 10.1111/cen.13356. Epub 2017 May 26.
Gestational diabetes (GDM) is characterized by maternal glucose intolerance that manifests during pregnancy. Because GDM resembles type 2 diabetes (T2DM), shared genetic predisposition is likely but has not been established. We tested the hypothesis that a genetic risk score (GRS) that included variants known to be associated with T2DM is associated with GDM.
We conducted a case-control study using the Vanderbilt Medical Center biobank (BioVU) and calculated a simple-count GRS using 34 variants previously associated with T2DM or fasting glucose in the general population, or with GDM or glucose intolerance in pregnancy. We assessed the association of the GRS with GDM adjusting for maternal age, parity, and body mass index (BMI) and calculated the area under the curve for the receiver-operating characteristic curve (c-statistic).
Among Caucasian women, we identified 458 cases of GDM and 1538 pregnant controls with normal glucose tolerance.
Cases of GDM had a higher number of risk alleles compared to controls (38.9±4.0 vs 37.4±4.0 risk alleles, P=1.6×10 ). The GRS was significantly associated with GDM; the adjusted odds ratio associated with each additional risk allele was 1.10 (95% CI: 1.07-1.13, P=6×10 ). Clinical variables predicted the risk of GDM (c-statistic 0.67, 95% CI: 0.64-0.70), and adding the GRS modestly improved prediction (0.70, 95% CI: 0.67-0.73).
Among Caucasian women, a GRS that included common T2DM genetic risk variants was associated with increased risk of GDM but showed limited utility in the identification of GDM cases.
妊娠期糖尿病(GDM)的特征是孕期出现母体糖耐量异常。由于GDM与2型糖尿病(T2DM)相似,可能存在共同的遗传易感性,但尚未得到证实。我们检验了这样一个假设,即包含已知与T2DM相关的变异的遗传风险评分(GRS)与GDM相关。
我们利用范德比尔特医疗中心生物样本库(BioVU)进行了一项病例对照研究,并使用34个先前与普通人群中的T2DM或空腹血糖相关,或与孕期GDM或糖耐量异常相关的变异计算了一个简单计数GRS。我们评估了GRS与GDM之间的关联,并对产妇年龄、产次和体重指数(BMI)进行了校正,同时计算了受试者工作特征曲线下面积(c统计量)。
在白人女性中,我们确定了458例GDM病例和1538例糖耐量正常的孕妇作为对照。
与对照组相比,GDM病例的风险等位基因数量更多(38.9±4.0个风险等位基因对37.4±4.0个风险等位基因,P=1.6×10 )。GRS与GDM显著相关;与每个额外风险等位基因相关的校正比值比为1.10(95%CI:1.07-1.13,P=6×10 )。临床变量可预测GDM风险(c统计量为0.67,95%CI:0.64-0.70),加入GRS可适度改善预测效果(0.70,95%CI:0.67-0.73)。
在白人女性中,包含常见T2DM遗传风险变异的GRS与GDM风险增加相关,但在识别GDM病例方面效用有限。